Edward J. Brennan, SVP of Medical Affairs at Medicus Pharma Ltd. (NASDAQ:MDCX), filed a Form 4 on November 17, 2026, disclosing the acquisition of 14,534 common shares on November 13, 2026, through a private placement subscription agreement.
Key Highlights
- Reporting person: Edward J. Brennan, SVP, Medical Affairs at Medicus Pharma Ltd.
- Transaction date: November 13, 2026, via a subscription agreement with the issuer.
- Shares acquired: 14,534 common shares, no par value, at a purchase price of $1.72 per share.
- Transaction type: Code A (Acquisition) in a private placement in which other investors also participated under separate subscription agreements.
- Post-transaction ownership: 28,029 common shares beneficially owned directly following the reported transaction.
- Filing signed by: Raza Bokhari, as Attorney-in-Fact, for Edward J. Brennan, dated November 17, 2026.
Brennan's Private Placement Purchase of Medicus Pharma Common Shares
According to the filing, Edward J. Brennan entered into a subscription agreement with Medicus Pharma Ltd. on November 13, 2026, under which he agreed to purchase 14,534 common shares, no par value, at a price of $1.72 per share. The filing describes this as a private placement in which other investors also participated under separate subscription agreements.
The transaction is recorded in Table I of the Form 4 as a direct acquisition (Code A). Prior to this purchase, Brennan held 13,495 common shares, calculated from the post-transaction total of 28,029 shares disclosed in the filing. The filing does not report any derivative securities held or transacted by the reporting person.
The form was filed on November 17, 2026, with Raza Bokhari signing as Attorney-in-Fact for Brennan. The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as that checkbox was not selected.
What Was Disclosed
Medicus Pharma Ltd.'s SVP of Medical Affairs, Edward J. Brennan, disclosed a direct acquisition of 14,534 common shares at $1.72 each through a private placement subscription agreement dated November 13, 2026, bringing his total direct beneficial ownership to 28,029 shares.




Please wait processing your request...